Last reviewed · How we verify

Urece — Competitive Intelligence Brief

Urece (DOTINURAD) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Immunology.

marketed Solute carrier family 22 member 12 Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Urece (DOTINURAD) — Fuji Yakuhin.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Urece TARGET DOTINURAD Fuji Yakuhin marketed Solute carrier family 22 member 12
Benzaron BENZARONE marketed benzarone Eyes absent homolog 3, Solute carrier family 22 member 12, Eyes absent homolog 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Urece — Competitive Intelligence Brief. https://druglandscape.com/ci/dotinurad. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: